1.840USDMkt Cap: 91.41M USDP/E: —Last update: 2026-05-22
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include Eng…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap91.41M USD
Enterprise Value21.42M USD
Revenue (TTM)300.00K USD
Gross Profit300.00K USD
Net Income (TTM)-18.38M USD
Revenue/Share0.0040 USD
Last Price1.840 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4510336096
Valuation
P/E (Trailing)—
P/E (Forward)-5.98
PEG—
EV/EBITDA-0.76
EV/Revenue71.40
P/S312.97
P/B0.84
EPS (TTM)-0.56
EPS (Forward)-0.32
52W Range
1.82011% of range2.000
52W High2.000 USD
52W Low1.820 USD
Profitability
Gross Margin100.00%
Oper. Margin-9653.00%
EBITDA Margin0.00%
Profit Margin-4594.25%
ROE-123.50%
ROA-79.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.30M USD
CapEx (TTM)16.00K USD
FCF Margin-4978.92%
FCF Yield-16.34%
Net Debt-72.47M USD
Net Debt/EBITDA2.56
Balance Sheet
Debt/Equity0.24
Current Ratio11.88
Quick Ratio11.50
Book Value/Sh2.245 USD
Cash/Share1.506 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 11, 2018
Splits
Last Split1:20
Split DateNov 29, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.533 USD
Target Range4.200 USD – 7.000 USD
# Analysts6
Ownership
Shares Out.49.68M
Float39.32M
Insiders1.71%
Institutions46.88%
Short Interest
Short Ratio4.3d
Short % Float9.52%
Short % Out.9.45%
Shares Short3.42M
Short (prev mo.)4.18M
Technical
SMA 501.906 (-3.5%)
SMA 2001.626 (+13.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)599.10K
Avg Vol (10d)840.72K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—